Hot Topics: Testicular Cancer - Improving Survivorship and Survival

Friday, October 31, 2025

15:15 - 16:45 GMT+0

Co-Chair(s)

Karima Oualla

Associate Professor of Medical Oncology
Hassan II University Hospital, Morocco
Scott Gilbert

Senior Member and Professor, Department of GU Oncology
Moffitt Cancer Center, United States

At the end of this session, attendees should be able to:

Examine the current landscape of biomarker development and their clinical utility for early diagnosis and surveillance of testicular cancer.
Recall management strategies for stage I and II seminoma and non-seminomatous germ cell tumors (NSGCT).
Examine the benefits, limitations, and technical considerations of robotic robotic retroperitoneal lymph node dissection (RPLND) in testicular cancer treatment.
Explore strategies for mitigating treatment-related toxicities and optimizing outcomes through multisciplinary patient-centered approaches.

15:15 - 15:25 GMT+0

Advancements in Biomarkers for Early Detection and Monitoring: Where Are We Now?
15:25 - 15:35 GMT+0

Management of stage I Seminoma/NSGCT: Optimizing psychosocial and gonadal outcomes
15:35 - 15:45 GMT+0

Management of Stage II Seminoma: Where Are We Now?
15:45 - 15:55 GMT+0

Robotic RPLND: Progress and Pitfalls
15:55 - 16:05 GMT+0

Long-term Survivorship: Managing Treatment Related Toxicity
16:05 - 16:15 GMT+0

Importance of Multi-disciplinary Approaches in Managing Testicular Cancer
16:15 - 16:25 GMT+0

Primum Non nocere: The Barts Experience
16:25 - 16:45 GMT+0

Case-based management of stage II NSGCT: perfecting outcomes